Obesity-associated exosomal miRNAs modulate glucose and lipid metabolism in mice

被引:327
作者
Castano, Carlos [1 ,2 ]
Kalko, Susana [1 ]
Novials, Anna [1 ,2 ]
Parrizas, Marcelina [1 ,2 ]
机构
[1] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Diabet & Obes Res Lab, Barcelona 08036, Spain
[2] Spanish Biomed Res Ctr Diabet & Associated Metab, Barcelona 08036, Spain
关键词
miRNA; exosome; glucose intolerance; adiposity; dyslipidemia; FREE FATTY-ACIDS; IN-VIVO; CIRCULATING MICRORNAS; INSULIN-RESISTANCE; HOMEOSTASIS; DYSFUNCTION; PROGRESSION; BIOMARKERS; PLASMA; CANCER;
D O I
10.1073/pnas.1808855115
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Obesity is frequently associated with metabolic disease. Here, we show that obesity changes the miRNA profile of plasma exosomes in mice, including increases in miR-122, miR-192, miR-27a-3p, and miR-27b-3p. Importantly, treatment of lean mice with exosomes isolated from obese mice induces glucose intolerance and insulin resistance. Moreover, administration of control exosomes transfected with obesity-associated miRNA mimics strongly induces glucose intolerance in lean mice and results in central obesity and hepatic steatosis. Expression of the candidate target gene Ppara is decreased in white adipose tissue but not in the liver of mimic-treated (MIMIC) mice, and this is accompanied by increased circulating free fatty acids and hypertriglyceridemia. Treatment with a specific siRNA targeting Ppara transfected into exosomes recapitulates the phenotype induced by obesity-associated miRNAs. Importantly, simultaneously reducing free fatty acid plasma levels in MIMIC mice with either the lipolysis inhibitor acipimox or the PPAR alpha agonist fenofibrate partially protects against these metabolic alterations. Overall, our data highlight the central role of obesity-associated exosomal miRNAs in the etiopathogeny of glucose intolerance and dyslipidemia.
引用
收藏
页码:12158 / 12163
页数:6
相关论文
共 33 条
[1]   BACE2 suppression promotes β-cell survival and function in a model of type 2 diabetes induced by human islet amyloid polypeptide overexpression [J].
Alcarraz-Vizan, Gema ;
Castano, Carlos ;
Visa, Montse ;
Montane, Joel ;
Servitja, Joan-Marc ;
Novials, Anna .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2017, 74 (15) :2827-2838
[2]   Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma [J].
Arroyo, Jason D. ;
Chevillet, John R. ;
Kroh, Evan M. ;
Ruf, Ingrid K. ;
Pritchard, Colin C. ;
Gibson, Donald F. ;
Mitchell, Patrick S. ;
Bennett, Christopher F. ;
Pogosova-Agadjanyan, Era L. ;
Stirewalt, Derek L. ;
Tait, Jonathan F. ;
Tewari, Muneesh .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (12) :5003-5008
[3]   MicroRNAs: Target Recognition and Regulatory Functions [J].
Bartel, David P. .
CELL, 2009, 136 (02) :215-233
[4]   Lowering plasma free fatty acids with acipimox mimics the antidiabetic effects of the β3-adrenergic agonist CL-316243 in obese Zucker diabetic fatty rats [J].
Blachère, JC ;
Pérusse, F ;
Bukowiecki, LJ .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2001, 50 (08) :945-951
[5]   Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence [J].
Boyle, James P. ;
Thompson, Theodore J. ;
Gregg, Edward W. ;
Barker, Lawrence E. ;
Williamson, David F. .
POPULATION HEALTH METRICS, 2010, 8
[6]   Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases [J].
Chen, Xi ;
Ba, Yi ;
Ma, Lijia ;
Cai, Xing ;
Yin, Yuan ;
Wang, Kehui ;
Guo, Jigang ;
Zhang, Yujing ;
Chen, Jiangning ;
Guo, Xing ;
Li, Qibin ;
Li, Xiaoying ;
Wang, Wenjing ;
Zhang, Yan ;
Wang, Jin ;
Jiang, Xueyuan ;
Xiang, Yang ;
Xu, Chen ;
Zheng, Pingping ;
Zhang, Juanbin ;
Li, Ruiqiang ;
Zhang, Hongjie ;
Shang, Xiaobin ;
Gong, Ting ;
Ning, Guang ;
Wang, Jun ;
Zen, Ke ;
Zhang, Junfeng ;
Zhang, Chen-Yu .
CELL RESEARCH, 2008, 18 (10) :997-1006
[7]   Peroxisome proliferator-activated receptor α-isoform deficiency leads to progressive dyslipidemia with sexually dimorphic obesity and steatosis [J].
Costet, P ;
Legendre, C ;
Moré, J ;
Edgar, A ;
Galtier, P ;
Pineau, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29577-29585
[8]   Type 2 diabetes mellitus [J].
DeFronzo, Ralph A. ;
Ferrannini, Ele ;
Groop, Leif ;
Henry, Robert R. ;
Herman, William H. ;
Holst, Jens Juul ;
Hu, Frank B. ;
Kahn, C. Ronald ;
Raz, Itamar ;
Shulman, Gerald I. ;
Simonson, Donald C. ;
Testa, Marcia A. ;
Weiss, Ram .
NATURE REVIEWS DISEASE PRIMERS, 2015, 1
[9]   miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting [J].
Esau, C ;
Davis, S ;
Murray, SF ;
Yu, XX ;
Pandey, SK ;
Pear, M ;
Watts, L ;
Booten, SL ;
Graham, M ;
McKay, R ;
Subramaniam, A ;
Propp, S ;
Lollo, BA ;
Freier, S ;
Bennett, CF ;
Bhanot, S ;
Monia, BP .
CELL METABOLISM, 2006, 3 (02) :87-98
[10]   Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis [J].
Fong, Miranda Y. ;
Zhou, Weiying ;
Liu, Liang ;
Alontaga, Aileen Y. ;
Chandra, Manasa ;
Ashby, Jonathan ;
Chow, Amy ;
O'Connor, Sean Timothy Francis ;
Li, Shasha ;
Chin, Andrew R. ;
Somlo, George ;
Palomares, Melanie ;
Li, Zhuo ;
Tremblay, Jacob R. ;
Tsuyada, Akihiro ;
Sun, Guoqiang ;
Reid, Michael A. ;
Wu, Xiwei ;
Swiderski, Piotr ;
Ren, Xiubao ;
Shi, Yanhong ;
Kong, Mei ;
Zhong, Wenwan ;
Chen, Yuan ;
Wang, Shizhen Emily .
NATURE CELL BIOLOGY, 2015, 17 (02) :183-+